Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy

BACKGROUND AND PURPOSE: Patients with recurrent cervical cancer (RecCC) who received definitive radiochemotherapy including image-guided adaptive brachytherapy (IGABT) as primary treatment are currently treated in our institution with palliative intent by chemotherapy (CHT) combined with bevacizumab...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Strahlenther Onkol
Autors principals: Sturdza, Alina, Hofmann, Sandra, Kranawetter, Marlene, Polterauer, Stephan, Grimm, Christoph, Krainer, Michael, Kirisits, Christian, Pötter, Richard, Reinthaller, Alexander, Schwameis, Richard
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696499/
https://ncbi.nlm.nih.gov/pubmed/28721510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00066-017-1178-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars